| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |